New Drugs AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women 5 years ago
New Drugs FDA Approves Symdeko (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of CF in Children Ages 6-11 Years with Certain Mutations in the CFTR Gene 5 years ago
Pharma Industry News As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority 5 years ago
Pharma Industry News England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right 5 years ago
Pharma Industry News Boosting natural repair could help solve age related macular degeneration 5 years ago